Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Merrimack Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Merrimack Pharma Amends Co-Development Agreement With Actavis 12
Merrimack Pharma Enters Into Co-Development Agreement With Cancer Treatment Centers of America 13
Licensing Agreements 14
Merrimack Pharma Enters into Licensing Agreement with Ipsen 14
Baxter International Enters into Licensing Agreement with Merrimack Pharma for MM-398 15
Merrimack Pharma Amends Licensing Agreement with PharmaEngine for MM-398 17
Equity Offering 19
Merrimack Pharma Plans to Raise up to USD40 Million in Public Offering of Shares 19
Merrimack Pharma Completes Public Offering Of Shares For US$28.8 Million 20
Merrimack Pharma Completes IPO For US$100 Million 22
Debt Offering 24
Merrimack Pharma Raises USD175 Million in Private Placement of 11.5% Notes Due 2022 24
Merrimack Pharma Completes Public Offering Of Notes Due 2020 For US$125 Million 25
Asset Transactions 27
Ipsen Acquires Oncology Assets from Merrimack Pharma 27
Merrimack Pharmaceuticals Inc – Key Competitors 29
Merrimack Pharmaceuticals Inc – Key Employees 30
Merrimack Pharmaceuticals Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Financial Announcements 32
Nov 07, 2018: Merrimack reports third quarter 2018 financial results and provides strategic update following portfolio review 32
Aug 07, 2018: Merrimack reports second quarter 2018 financial results 34
May 08, 2018: Merrimack Reports First Quarter 2018 Financial Results 36
Mar 12, 2018: Merrimack Reports 2017 Financial Results 37
Nov 08, 2017: Merrimack Reports Third Quarter 2017 Financial Results 39
Aug 09, 2017: Merrimack Reports Second Quarter 2017 Financial Results 40
May 10, 2017: Merrimack Reports First Quarter 2017 Financial Results 41
Mar 01, 2017: Merrimack Reports Fourth Quarter and Full-Year 2016 Financial Results 43
Corporate Communications 45
Feb 20, 2018: Merrimack Announces Formation of New Scientific Advisory Board with Extensive Expertise in Precision Oncology 45
Nov 30, 2017: Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors 46
Aug 14, 2017: Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer 47
Jun 08, 2017: Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources 48
May 25, 2017: Merrimack Announces Management Change 49
Jan 18, 2017: Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO 50
Clinical Trials 51
Jun 19, 2017: Merrimack Announces Completion of Enrollment in Phase 2 CARRIE Study of MM-141; Data Expected in First Half of 2018 51
Mar 27, 2017: Merrimack to Present Data on Istiratumab (MM-141) at the 2017 American Association for Cancer Research Annual Meeting 52
Mar 27, 2017: Merrimack to Present Data on MM-151 at the 2017 American Association for Cancer Research Annual Meeting 53
Mar 27, 2017: Merrimack to Present Data on MM-161 at the 2017 American Association for Cancer Research Annual Meeting 54
Mar 27, 2017: Merrimack to Present Data on MM-310 at the 2017 American Association for Cancer Research Annual Meeting 55
Mar 23, 2017: Merrimack Initiates Phase 1 Study of MM-310 in Solid Tumors 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Merrimack Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Merrimack Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Merrimack Pharma Amends Co-Development Agreement With Actavis 12
Merrimack Pharma Enters Into Co-Development Agreement With Cancer Treatment Centers of America 13
Merrimack Pharma Enters into Licensing Agreement with Ipsen 14
Baxter International Enters into Licensing Agreement with Merrimack Pharma for MM-398 15
Merrimack Pharma Amends Licensing Agreement with PharmaEngine for MM-398 17
Merrimack Pharma Plans to Raise up to USD40 Million in Public Offering of Shares 19
Merrimack Pharma Completes Public Offering Of Shares For US$28.8 Million 20
Merrimack Pharma Completes IPO For US$100 Million 22
Merrimack Pharma Raises USD175 Million in Private Placement of 11.5% Notes Due 2022 24
Merrimack Pharma Completes Public Offering Of Notes Due 2020 For US$125 Million 25
Ipsen Acquires Oncology Assets from Merrimack Pharma 27
Merrimack Pharmaceuticals Inc, Key Competitors 29
Merrimack Pharmaceuticals Inc, Key Employees 30
Merrimack Pharmaceuticals Inc, Subsidiaries 31
List of Figures
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Merrimack Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Merrimack Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10